About Entopsis
Entopsis is a company based in Miami (United States) founded in 2011. Entopsis has raised $1.05 million across 3 funding rounds from investors including Krillion Ventures, G3 Capital Partners and Breakout Ventures. Entopsis offers products and services including NuTec, OpsisDx, and PCRopsis Oral Rinse. Entopsis operates in a competitive market with competitors including Tethis, GNA Biosolutions, NanoVation-GS, AlphaSIP and Ellume, among others.
- Headquarter Miami, United States
-
Sectors
Technology
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Entopsis Llc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$1.05 M (USD)
in 3 rounds
-
Latest Funding Round
$250 K (USD), Seed
Dec 14, 2016
-
Investors
Krillion Ventures
& 2 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Entopsis
Entopsis offers a comprehensive portfolio of products and services, including NuTec, OpsisDx, and PCRopsis Oral Rinse.
Device for unbiased molecular identification in health monitoring.
Platform for detecting and distinguishing multiple analytes in samples.
Tool for simple oral sample collection and transportation for testing.
People of Entopsis
Unlock access to complete
Unlock access to complete
Unlock access to complete
Funding Insights of Entopsis
Entopsis has successfully raised a total of $1.05M across 3 strategic funding rounds. The most recent funding activity was a Seed round of $250 thousand completed in December 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Entopsis
Entopsis has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include Krillion Ventures, G3 Capital Partners and Breakout Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
A venture capital fund based in Miami is operated.
|
Locked | Locked | Locked | |
|
Limited information is provided about G3 Capital Partners.
|
Locked | Locked | Locked | |
|
Early-stage science-driven companies are supported through venture capital investments.
|
Locked | Locked | Locked |
Investor details for Entopsis
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Entopsis
Investment portfolio details for Entopsis
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Entopsis
Detailed financials for Entopsis
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Entopsis Comparisons
Peer comparison for Entopsis
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Entopsis
Entopsis operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Tethis, GNA Biosolutions, NanoVation-GS, AlphaSIP and Ellume, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Automated solutions for liquid biopsy processing are provided.
|
|
| Locked | Locked | Locked |
Instruments and assays for molecular pathogen detection are developed.
|
|
| Locked | Locked | Locked |
Nanomaterial-based sensors for respiratory monitoring devices are developed.
|
|
| Locked | Locked | Locked |
Nanotube-based biosensor chips are produced for real-time medical diagnostics.
|
|
| Locked | Locked | Locked |
Developer of a diagnostic device that uses quantum dot nanoparticles to provide real-time patient testing
|
Detailed competitors of Entopsis
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Entopsis
Complete news archive for Entopsis
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Entopsis
Entopsis was founded in 2011 and raised its 1st funding round 1 year after it was founded.
Entopsis is headquartered in Miami, United States. It is registered at Miami, Florida, United States.
Entopsis is a funded company, having raised a total of $1.05M across 3 funding rounds to date.
Specialized glass slides known as NUTEC were developed by the company, founded in 2011 and based in Miami, United States, to enable detection of DNA, RNA, proteins, and small molecules through colorimetric changes. Software utilizing machine learning is provided for data analysis. Operations focus on diagnostics in oncology, autoimmune conditions, and rare diseases within the health technology sector.
Entopsis's top competitors include Tethis, GNA Biosolutions and NanoVation-GS.
Entopsis offers NuTec, OpsisDx, and PCRopsis Oral Rinse.
Entopsis has 3 investors. Key investors include Krillion Ventures, G3 Capital Partners, and Breakout Ventures.